These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


262 related items for PubMed ID: 12347721

  • 1. Coagulation and thrombosis with OC use: physiology and clinical relevance.
    Comp PC.
    Dialogues Contracept; 1996; 5(1):1-3. PubMed ID: 12347721
    [Abstract] [Full Text] [Related]

  • 2. Oral contraceptives and venous thromboembolism: consensus conference statement.
    Dialogues in Contraception Consensus Conference (1995: Chicago).
    Dialogues Contracept; 1996; ():1-8. PubMed ID: 12320455
    [Abstract] [Full Text] [Related]

  • 3. A perspective on the concept of "risk".
    Westhoff CL.
    Dialogues Contracept; 1996; 5(1):8-9. PubMed ID: 12347723
    [Abstract] [Full Text] [Related]

  • 4. [Combined contraceptives and cardiovascular risk].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [Abstract] [Full Text] [Related]

  • 5. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996 Dec; (39):2-3. PubMed ID: 12292198
    [Abstract] [Full Text] [Related]

  • 6. [Veins and contraception].
    Reinharez D, Monsonego J.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [Abstract] [Full Text] [Related]

  • 8. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology of venous thromboembolic disease and OC use.
    Ory HW.
    Dialogues Contracept; 1996 Apr; 5(1):4-7, 10. PubMed ID: 12347722
    [Abstract] [Full Text] [Related]

  • 10. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 18. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP.
    Contracept Fertil Sex (Paris); 1985 Jan 16; 13(1 Suppl):121-6. PubMed ID: 12280197
    [Abstract] [Full Text] [Related]

  • 19. German court lifts OC prescription ban.
    Contracept Technol Update; 1998 Mar 16; 19(3):41-2. PubMed ID: 12293274
    [Abstract] [Full Text] [Related]

  • 20. [Oral contraception, glucid metabolism and monitoring criteria].
    Gaspard U.
    Contracept Fertil Sex (Paris); 1988 Feb 16; 16(2):113-8. PubMed ID: 12342000
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.